dextroamphetamine has been researched along with Neoplasms in 8 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatigue is very common in patients with cancer." | 2.74 | A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. ( Auret, KA; Bremner, AP; Bulsara, M; Schug, SA, 2009) |
| "Fatigue is a highly prevalent and distressing symptom associated with significant psychological and functional morbidity and decreased quality of life among patients with cancer." | 2.46 | Psychostimulants for cancer-related fatigue. ( Alici, Y; Breitbart, W, 2010) |
| "Methylphenidate has been studied most and seems to be effective and well tolerated despite common side effects." | 2.44 | Update on psychotropic medications for cancer-related fatigue. ( Alici-Evcimen, Y; Breitbart, W, 2007) |
| "Depressive symptoms associated with cancer range from normal sadness through acute stress response to major depression." | 1.27 | Diagnosis and treatment of depression in the cancer patient. ( Holland, JC; Massie, MJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustian, KM | 1 |
| Alfano, CM | 1 |
| Heckler, C | 1 |
| Kleckner, AS | 1 |
| Kleckner, IR | 1 |
| Leach, CR | 1 |
| Mohr, D | 1 |
| Palesh, OG | 1 |
| Peppone, LJ | 1 |
| Piper, BF | 1 |
| Scarpato, J | 1 |
| Smith, T | 1 |
| Sprod, LK | 1 |
| Miller, SM | 1 |
| Auret, KA | 1 |
| Schug, SA | 1 |
| Bremner, AP | 1 |
| Bulsara, M | 1 |
| Breitbart, W | 2 |
| Alici, Y | 1 |
| GRAHN, HV | 1 |
| Alici-Evcimen, Y | 1 |
| Massie, MJ | 1 |
| Holland, JC | 1 |
| Yee, JD | 1 |
| Berde, CB | 1 |
| Homsi, J | 1 |
| Walsh, D | 1 |
| Nelson, KA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility Study of a Hypnosis Intervention and a Cognitive Behavioral Therapy Intervention to Reduce Fatigue in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer[NCT04999306] | 60 participants (Anticipated) | Interventional | 2023-05-17 | Recruiting | |||
| Clinical Study on Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Adjuvant Chemotherapy[NCT06137833] | 92 participants (Anticipated) | Interventional | 2023-11-27 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dextroamphetamine and Neoplasms
| Article | Year |
|---|---|
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphen | 2017 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphen | 2017 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphen | 2017 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphen | 2017 |
Psychostimulants for cancer-related fatigue.
Topics: Central Nervous System Stimulants; Dextroamphetamine; Fatigue; Humans; Methylphenidate; Neoplasms; W | 2010 |
Update on psychotropic medications for cancer-related fatigue.
Topics: Antidepressive Agents; Central Nervous System Stimulants; Dextroamphetamine; Fatigue; Humans; Methyl | 2007 |
Psychostimulants in supportive care.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Child; Dextroamphetamine; Ephedrine; Humans; Men | 2000 |
1 trial available for dextroamphetamine and Neoplasms
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer.
Topics: Aged; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Fatigue; Female; Hu | 2009 |
3 other studies available for dextroamphetamine and Neoplasms
| Article | Year |
|---|---|
Use of a d-amphetamine-amobarbital combination as an adjunct to the treatment of carcinoma.
Topics: Amobarbital; Amphetamine; Amphetamines; Anxiety; Barbiturates; Depression; Depressive Disorder; Dext | 1954 |
Diagnosis and treatment of depression in the cancer patient.
Topics: Adjustment Disorders; Antidepressive Agents, Tricyclic; Asparaginase; Combined Modality Therapy; Dep | 1984 |
Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Analgesics, Opioid; Dextroamphetamine; Female; Humans; M | 1994 |